Clarification on the impact of cervarix vaccination on human papillomavirus infection and cervical cancer in the United Kingdom

Hum Vaccin Immunother. 2016 Jul 2;12(7):1940-2. doi: 10.1080/21645515.2016.1143159.

Authors

Darron Brown¹, Amit Sharad Kulkarni², Matt Pillsbury², Alain Luxembourg², Alfred Saah²

Affiliations

¹ a Department of Medicine , Indiana University School Of Medicine , Indianapolis , IN , USA.
² b Merck & Co, Inc , Kenilworth , NJ , USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Female
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Papillomavirus Infections*
Papillomavirus Vaccines
United Kingdom
Uterine Cervical Neoplasms*
Vaccination

Substances

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Papillomavirus Vaccines
human papillomavirus vaccine, L1 type 16, 18